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1. INTRODUCTION
Arterial stiffness increases through life due to changes in smooth 
muscle and endothelial function, and alteration of the extracellular 
matrix through elastin degeneration, collagen cross-linking, and 
calcification. These processes occur with age and are accelerated 
in certain diseases including hypertension, diabetes mellitus, and 
end-stage renal failure [1]. Arterial stiffness as a predictor of cardio-
vascular disease particularly in the elderly [2] has been receiving 
increasing interest in preventive health care. The association 
between cardiovascular disease risk factors and measures of arterial 
stiffness has been demonstrated in large-population studies [3–5]. 
Arterial stiffness has been linked to vascular morbidity and mortal-
ity in cohorts with hypertension [6,7], end-stage renal disease [8], 
and type 2 diabetes mellitus [9].
There is increasing recognition that the interrelations between 
arterial stiffness and cardiovascular events are mediated by micro-
vascular remodelling and obliteration [10,11]. Human and animal 
studies have evidenced arteriolar remodelling and capillary rar-
efaction in early stages of hypertension [12]. The possibility that 
the microcirculatory impairment may occur early in the onset of 
increasing arterial stiffness underlines the importance of monitor-
ing microcirculation for more effective preventive and therapeutic 
measures [13].
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A B S T R AC T
Purpose: The retinal vasculature provides unique in vivo access to the microcirculation and presents the possibility of measuring 
small artery (retinal) stiffness using pulse wave velocity (PWV). This study investigates whether retinal artery PWV (rPWV) has 
a blood pressure (BP) dependency.
Methods: Fundus videos from eight Sprague-Dawley rats aged 12 weeks were captured (Zeiss fundus microscope with high-speed 
camera, 125 fps, Optronis, Germany) simultaneously with aortic BP. Retinal artery diameter waveforms at proximal and distal sites 
were extracted and transit time calculated from the phase delay between frequency components (4–6 Hz, typical heart rate of rats) 
of the waveforms. rPWV was measured across a physiological range of mean arterial pressure (MAP): baseline (90–110 mmHg); 
130 mmHg to baseline following systemic phenylephrine (PE) infusion (30 mg/kg/min); 130 mmHg to baseline during PE infusion 
with simultaneous inferior vena cava occlusion (VO); 70 mmHg to baseline following systemic sodium nitroprusside infusion; and 
70 mmHg to baseline following VO. The correlation between retinal artery rPWV and BP was quantified.
Results: There was a significant positive correlation between retinal artery rPWV and MAP as expected (0.19 mm/s/mmHg, 
R2 = 0.59, p < 0.001). There was a positive correlation between retinal and aortic PWV (R2 = 0.09, p = 0.03).
Conclusion: The pressure dependency of the measured rPWV indicates the measure has utility in in vivo quantification of the 
impact on microvessels of cardiovascular diseases. To elucidate the predictive value of screening rPWV in systemic cardiovascular 
abnormalities, the relation needs to be investigated in humans.
H I G H L I G H T S
 • Retinal pulse wave velocity (rPWV) presents the opportunity for measuring small vessel arterial stiffness in vivo.
 • rPWV measurement relies on complex image filtering to obtain diameter waveforms, bringing uncertainty as to whether the 
measure does reflect arterial stiffness.
 • This study measures rPWV in the rat showing that it varies with blood pressure, a fundamental property of material stiffness 
of arteries.
 • This indicates that the rPWV measure is associated with arterial stiffness.
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The eye fundus has been traditionally used for identification of vas-
cular changes. The advent of emerging ophthalmic imaging tech-
niques in recent years has been translated into a more advanced 
investigation of disease phenotype through the eyes. The microcir-
culation can be directly and non-invasively monitored and imaged 
via the retina. Since the cornea and lens in the anterior segment 
of the eye are transparent and avascular, and the vitreous in the 
posterior segment also, retinal circulation can be easily and non- 
invasively visualized and imaged. The retina has a rich vascular 
network which shares the same embryological origin and common 
histological, anatomical, and physiological characteristics with the 
heart and brain [14]. Moreover, retinal vessels and cardio- vasculature 
are impacted by the same intrinsic and environmental factors. 
Therefore, retinal vascular changes are clinically highly relevant to 
cardio- and cerebrovascular pathologies.
These advantageous characteristics make the retina an ideal 
window to study not only ocular but also vascular related pathogen-
esis. Prior studies have provided strong evidence for retinal vascu-
lar changes in association with different types of disease including 
stroke [15], dementia [16], Alzheimer’s disease [17], hypertension 
[18], aortic stiffness [19], diabetes [13], glaucoma [20], and sleep 
apnea [21]. In particular, retinal arteriolar narrowing, widening of 
retinal veins, and arteriovenous nipping are hypertensive retinop-
athy signs which have been evidenced to correlate with cardiovas-
cular events [22–24].
These studies use static vessel dimensions to characterise small 
vessel disease. They do not quantify the stiffness of the retinal 
arteries. High speed video imaging of the retina presents the oppor-
tunity of measuring retinal artery pulse wave velocity (rPWV), a 
correlate of material stiffness. Measurement of rPWV is not yet a 
standard. Due to the image processing and algorithmic complexi-
ties in assessing rPWV, it is difficult to ascertain if rPWV is a sur-
rogate of retinal artery stiffness, given the intrinsic association of 
pulse wave velocity with arterial stiffness.
The current study investigates whether measured rPWV is (a) 
affected by vasoactive drugs and (b) changes with blood pressure 
(BP). Changes in rPWV in the correct direction with administra-
tion of vasoactive drugs and/or BP changes would indicate that the 
measure is reflective of retinal artery stiffness. This study mimics a 
methodology presented by Butlin et al. [25] quantifying the BP and 
vasoactive drug effect on large artery (aortic) stiffness in rats, but 
applied to the study of rPWV as a way of investigating the pressure, 
and vasoactive drug dependency of retinal artery stiffness, as mea-
sured by rPWV, in the rat.
2. MATERIALS AND METHODS
2.1. Animal Preparation
Experiments were performed on eight Sprague-Dawley rats (five 
female) aged 12 weeks with a total of 11 eyes (six right eyes and 
five left eyes) analysed between the eight rats. All experiments were 
conducted in accordance with the Australian Code for the Care and 
Use of Animals for Scientific Purposes and were approved by the 
Macquarie University Animal Ethics Committee.
Anaesthesia was induced with urethane (ethyl carbamate, 1.3 g/kg) 
administered intraperitoneally and maintained by intravenous 
urethane as required. Rats were placed in a supine position on a 
heat mat regulated via a rectal temperature probe. Two femoral 
veins were cannulated for intravenous infusion of anaesthetic and 
vasoactive drugs. For the purpose of aortic PWV (aPWV) measure-
ment, two 1.2 F solid state pressure catheters (Transonic Scisense, 
London, Canada) were advanced via the left carotid and femoral 
arteries and into the descending aorta just distal to the aortic arch 
and just proximal to the iliac bifurcation. Pressure waveforms were 
used to ascertain proper location of transducers and catheter place-
ment was confirmed post-mortem. A suture was placed loosely 
around the inferior vena cava accessed via a right flank incision 
and externalized for later application of tension to reduce venous 
return for drug-independent lowering of BP. The electrocardio-
gram (ECG) was monitored using lead II of a three-lead electrode 
configuration throughout the experiments. BP variations for each 
rat were compared with their own baseline.
Blood pressure and ECG signals were recorded throughout the 
experiment with the ECG sampled at 2 kHz and the BP wave-
forms sampled at 10 kHz (Power 1401 data acquisition system, 
Spike2 software version 7.09, Cambridge Electronic Design Ltd, 
Cambridge, England).
2.2. Retinal Imaging
The animal was placed prone on the microscope stage for eye imag-
ing. The pupil was dilated by a single drop of 0.5% tropicamide 
(Alcon, Fort Worth, Texas, USA). Gen Teal moisturizing eye gel 
(0.3% Hypromellose ophthalmic gel) was also applied to moisten 
and clarify the surface of the cornea. 0.9% saline (sodium chloride) 
solution was used as required during the experiment to hydrate and 
lubricate the eye. Retinal images were recorded for offline analysis 
using a high-speed camera (Optronis, Kehl, Germany) mounted on 
a Zeiss ff450Plus fundus camera (Zeiss, Oberkochen, Germany) at a 
rate of 125 frames per second with a 30° field of view at a resolution 
of 1280 × 1024 pixels. The final spatial resolution of the whole opti-
cal imaging system was 6.06 mm.
2.3. Alteration of Blood Pressure
Following a 10 s recording of signals and retinal video at baseline 
resting anaesthetized conditions, retinal and aortic BP recordings 
were acquired across a physiological range of BP achieved through 
vasoactive substances and through a passive mechanism. About 40-s 
long retinal recordings were obtained across each of the following 
mean arterial pressure (MAP) ranges achieved in the following ways:
 • 130 mmHg to baseline BP following systemic phenylephrine 
(PE) infusion;
 • 130 mmHg to baseline BP during PE infusion with simultaneous 
inferior vena cava occlusion (referred to as PEVO in this article);
 • 70 mmHg to baseline BP following systemic sodium nitroprus-
side (SNP); and
 • 70 mmHg to baseline BP following venous occlusion (VO).
Phenylephrine and SNP were administered intravenously at a dose 
rate of 30 mg/kg/min. PE is an a1-adrenoceptor agonist which binds 
to a-receptors on vascular smooth muscle and increases BP by 
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inducing vasoconstriction. SNP mediates vasodilation by releasing 
nitric oxide. It has been shown that these drugs have minimal effect 
on aortic stiffness in humans [26] and in rats [25]. It is assumed 
that the effect is imparted mostly on the peripheral vasculature 
and this is likely to include the retinal vasculature. Therefore, this 
experiment used a passive means of changing BP (VO) to compare 
to the drug-induced method to quantify the direct drug effect on 
retinal artery stiffness as opposed to the BP effect.
2.4.  Calculation of Retinal Artery Diameter 
and Pulse Wave Velocity
Retinal artery diameter waveforms at proximal and distal sites were 
obtained using an in-house algorithm written in MATLAB® (The 
MathWorks Inc., Natick, MA, USA). The algorithm is composed 
of three modules: vessel segmentation, diameter measurement and 
calculation of pulse transit time. The vessel segmentation method 
starts with an adaptive contrast adjustment procedure to enhance 
the intensity of the vessels against the background. Next, the entire 
sequence of images is registered to align the frames and compen-
sate for motion artefacts produced by the eye and the respiratory 
displacements. To achieve more accurate diameter measurements 
at a faster speed and less computational cost, an artery is selected 
interactively by the user by drawing a line crossing the boundar-
ies of the vessel of interest at both sides. Given the length of the 
vessel segment to be analysed, the algorithm automatically crops 
the vessel segment from all frames. The rest of the algorithm oper-
ates on this region of interest cropped from the image sequence 
rather than whole frames. For a precise segmentation of the vessel 
boundaries, image artefacts are first removed by an anisotropic dif-
fusion filter. Using an edge detection algorithm, the boundaries of 
the vessel segment are defined. The diameter of the vessel is mea-
sured as the Euclidean distance between the intersection pairs of 
the input line with the vessel boundaries at each side. To obtain 
more robust and accurate measurements, the algorithm measures 
the diameter along four parallel lines shifted by one or two pixels 
on each side of the input line. After computing the intersections, 
missing values and outliers are replaced by spline interpolation. To 
obtain rPWV, proximal and distal points were set along a straight 
segment of an artery approximately 420 mm apart. This distance 
was selected to avoid vessel bifurcations and intensity variations 
along the vessel segment due to concave shape of the retina.
In eight out of 11 eyes, vessel diameter changes were taken in the 
superior nasal quadrant of the fundus and within one to three optic 
disc diameter from the optic disc rim. In the remaining three eyes, 
image quality was not suitable in that same quadrant and measure-
ments were made in the superior temporal segment. rPWV was 
then calculated as the ratio of the distance between two places of 
diameter measurement to the time taken for a pulse to travel that 
distance. The pulse transit time was calculated as the slope of the 
regression line of phase delays on angular frequencies obtained 
from the Fourier components of proximal and distal diameter 
waveforms. Fourier analysis was performed on the whole duration 
of diameter waveforms (i.e. 10 s for the baseline and 40 s for each 
episode of BP manipulation) to obtain a higher frequency reso-
lution and consequently more precise time delay measurements. 
The regression was calculated only for the frequency components 
between 4 and 6 Hz covering the cardiac frequency of rats.
2.5. Calculation of Aortic Parameters
Mean arterial pressure, systolic blood pressure (SBP), diastolic 
blood pressure (DBP), heart rate (HR), and aPWV were extracted 
from ECG, thoracic, and abdominal pressure waveform using a 
custom script written in Spike2 software (Version 7.09, Cambridge 
Electronic Design Ltd). Aortic pulse transit time was calculated as 
the foot-to-foot time interval between the thoracic and abdominal 
pressure waves. The foot of the signals was located using the peak 
of the second derivative of the pressure waveforms. The distance 
between the sensors was measured at autopsy using a wetted suture 
placed directly along the aorta between the two pressure sensors, 
and the length of the suture segment measured using a ruler.
2.6. Statistical Analysis
Difference in rPWV between active (vasoactive drug) and passive 
(venous occlusion) methods of altering BP were analysed by analy-
sis of variance with post-hoc Tukey’s Honest Significant Difference 
tests. Linear mixed model analysis was conducted to find predic-
tors of rPWV.
3. RESULTS
Figure 1A shows a representative retinal arterial diameter wave-
form. Although a clear cardiac related waveform is not visu-
ally apparent, the diameter signal exhibits power at the cardiac 
frequency (Figure 1B).
The average pressure range analysed following PE infusion did 
not differ from the pressure range during PE infusion with venous 
occlusion (PEVO, Figure 2A). Similarly, the pressure range anal-
ysed following SNP infusion did not differ from VO (Figure 2A). 
Therefore, rPWV results could be compared between the active 
and passive BP altering mechanisms. The manipulations to raise 
BP gave the expected significantly higher pressure to the manip-
ulations to lower BP (Figure 2A). Along with the measurements 
at anaesthetised resting BP, the data gave results across a range of 
physiological BP.
Vasoactive drugs did not affect rPWV (Figure 2B), with results 
following PE infusion (12.7 ± 1.7 mm/s) not differing from those 
during PE infusion and venous occlusion (12.2 ± 1.6 mm/s, 
p = 1.00) following correction for multiple comparison). Results 
following SNP infusion (7.7 ± 0.5 mm/s) did not differ from those 
following venous occlusion (9.2 ± 0.8 mm/s, p = 0.35). rPWV 
curves as a function of DBP, SBP, and MAP for each of the episodes 
are depicted in Figure 3.
There was a positive correlation between rPWV and MAP 
(R2 = 0.69, p < 0.001, Figure 4A) and between rPWV and aPWV 
(R2 = 0.09, p = 0.03; Figure 4B). Incorporation of random effects 
specified for between animal and within episodes for each eye in a 
linear mixed model resulted in a significant main effect of aPWV 
was found in rPWV as rPWV = 4.74 × 10−3 × aPWV − 0.61 × sex 
− 1.09 × eye side − 18.44 (R = 0.65, p < 0.0001). This means that 
rPWV increases with aPWV with a slope of 4.74 × 10−3 and when 
aPWV and sex are held constant, rPWV would be −1.09 mm/s 
slower in the left eye compared with the right eye.
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Figure 1 | Retinal arterial diameter waveform (A) have power at cardiac frequency (B).
A B
Figure 2 | Average (A) mean arterial pressure (MAP) and (B) retinal artery pulse wave velocity (rPWV) following infusion of phenylephrine (PE), sodium 
nitroprusside (SNP) and the use of venous occlusion (VO) as means of manipulating blood pressure; **p < 0.01.
A B
Figure 3 | Retinal artery pulse wave velocity (rPWV) regression against diastolic (DBP), systolic (SBP), and mean arterial blood pressure (MAP) 
comparing blood pressure achieved by either (A–C) phenylephrine infusion (PE) or phenylephrine infusion during venous occlusion (PEVO), or  
(D–F) sodium nitroprusside infusion (SNP) or venous occlusion (VO).
A
D
B
E
C
F
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Figure 4 | Linear regression of retinal artery pulse wave velocity (rPWV) against (A) mean arterial pressure (MAP), and (B) aortic pulse wave 
velocity (aPWV).
4. DISCUSSION
Utilizing high-speed retinal imaging the transit time of the pulse 
along the retinal arteries of rodents was able to be quantified from 
data related to retinal artery diameters. The study is the first to show 
that the calculated rPWV from these transit times, as a measure 
of retinal artery stiffness, was not changed directly by vasoactive 
drugs but was correlated with systemic arterial pressure and aPWV.
Pulse wave velocity in macro-vessels as a measure of arterial stiff-
ness is highly correlated with BP, this being a fundamental prop-
erty of arterial biomechanics. Large artery stiffness also increases 
with age and during cardiovascular disease progression [27]. As 
large artery stiffness can be measured in humans (and animals) 
non- invasively makes it a useful summative marker of the effect 
of age and disease on the vasculature. There is much less research 
in arterial stiffness alterations in microvessels largely due to the 
limitations in non-invasive assessment of microvessels. The eye 
provides a window to microvessels and the measurement of rPWV 
could provide a quantitative assessment of microvessel stiffness. 
However, the diameter waveforms acquired (Figure 1A) require 
significant processing to arrive at a value of pulse transit time and 
rPWV reducing the confidence that the rPWV being measured is 
accurate and reflective of microvessel stiffness. Perhaps due to the 
degree of processing required, rPWV values reported in the lit-
erature have varied in order of magnitude considerably. The first 
attempt to measure rPWV in the rat retina using a similar imaging 
modality [28] reported an average rPWV of 114 mm/s in Wistar-
Kyoto rats and 98 mm/s in Sprague-Dawley rats which differ by one 
order of magnitude from the values reported in this study. In 2016, 
an investigation of the mouse retina by Song et al. [29] using swept-
source OCT concluded that rPWV of more than 1 m/s is expected. 
The discrepancy between reported values of rPWV resulted in 
debate between researchers in the field [30,31]. This study does not 
tackle the issue of order of magnitude of the rPWV measure but 
attempts to validate the rPWV measure by demonstrating that it 
changes with BP – a fundamental property of arterial stiffness. BP 
was changed through use of vasoactive substances, and to ensure 
that the vasoactive substances themselves did not affect stiffness, 
these results were compared with methods using a BP-altering 
method independent of vasoactive drugs.
The current study found a strong association between rPWV and 
BP indicating increased stiffness in the retinal artery with increas-
ing BP. In the human carotid artery, there is an average change 
of 1 m/s for a change of pressure of 10 mmHg [32]. This current 
investigation on the rat showed an average increase of 1.9 mm/s in 
rPWV for a 10 mmHg increase in MAP compared with a rate of 
0.1 m/s per 10 mmHg in the rat aorta. The rPWV therefore shows 
the expected directional change with change in MAP, and expected 
greater sensitivity at higher BP. The further implication is that the 
same level of increase in BP results in a more pronounced increase 
in rPWV than aPWV.
The rPWV/BP relationship fitted an exponential model (R2 = 0.64, 
p < 0.0001) instead of a second-order polynomial (R2 = 0.71, 
p < 0.0001) as obtained in the aorta [25]. This might be attributed 
to the structural difference between the aorta and retinal vessels. 
With varying arterial wall properties, PWV dependency on BP 
might be expected to be different between proximal, more elastic 
and peripheral, more muscular arteries. Retinal arteries are also 
unique (along with cerebral vessels) in that they exist in a posi-
tive pressure environment. Intraocular pressure (IOP) alters the 
transmural pressure, the pressure determinant of arterial stiffness. 
Although it is assumed that IOP under anaesthetised conditions 
was relatively constant though it was not measured. However, 
physiological IOP changes are in the range of up to 10 mmHg and 
unlikely to have significantly affected the result over the systemic 
BP changes measured.
The pressure sensitivity of rPWV was greater at higher levels of BP 
similar to that observed in large arteries [25]. This was evidenced 
both as greater sensitivity of rPWV to SBP compared with DBP and 
when comparing pressure sensitivity of rPWV during PE/PEVO 
episodes with that during SNP/VO. Prior to this study the pres-
sure dependency of rPWV was only evidenced cross-sectionally by 
comparison of normotensive and hypertensive young subjects [33], 
which may be a change in rPWV evoked by differences in systemic 
BP and/or differences in underlying retinal artery characteristics 
under chronic hypertensive conditions. The current study demon-
strated the acute effects of BP on rPWV prior to irreversible struc-
tural damages in micro- and macro-vessels. Given the homology 
between retinal microvasculature and peripheral small resistant 
A B
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arteries, this novel observation is of interest in in vivo non-invasive 
evaluation of microvascular changes associated with hypertension 
and arterial stiffness.
This study, for the first time reports a positive correlation 
between rPWV and aPWV in rodents. This provides further con-
firmation of the validity of rPWV. However, the common factor 
in both measures is the dependency on BP and therefore it would 
be expected that if rPWV is correlated with BP, it would also be 
correlated with aPWV.
One limitation of this study is that we were only able to measure 
average rPWV throughout each episode of BP manipulation, pro-
viding an average rPWV over a BP range and not a single value 
of rPWV for a single BP point. Dividing the 40-s recording into 
shorter epochs resulted in regression of phase shifts on frequency 
that were non-significant due to insufficient number of fast Fourier 
transform samples. Therefore, the method as currently proposed is 
most useful under conditions of stable BP.
Retinal vasculature provides an opportunity for non-invasive 
measurement of arterial stiffness in small vessels. Recent pub-
lished studies have reported attempts to non-invasively quan-
tify rPWV [28,31,33–35]. However, the reported values in those 
studies yield variable results bringing into doubt the accuracy of 
the measurements. By measuring material stiffness and geome-
try of retinal arteries, the order of magnitude of rPWV can be 
determined using the Moens–Korteweg equation. To estimate 
the theoretical value of rPWV, the effect of blood viscosity 
needs to be accounted for. Considering viscosity of blood, the 
wave propagation speed of oscillatory flow is characterised by 
a non-dimensional a parameter which is related to the vessel 
radius (r), frequency of oscillation (w), fluid density (r), and 
fluid viscosity (m) as follows:
   a
wr
m
= r   (1)
By taking into account the effect of a parameter for the oscillatory 
flow of a fluid with finite viscosity, lower PWV values by 1–2 orders 
of magnitude difference with PWV in large arteries are expected in 
vessels of size of retinal arteries (50–100 mm) [36].
5. CONCLUSION
This study provides validation of rPWV measurement in 
rodents by demonstrating that the measure of rPWV shows the 
expected dependency on BP and correlates with large artery 
stiffness. The associations between rPWV and both BP and 
aPWV though expected based on physiological evidence, had 
not been corroborated before. Further research is required to 
establish the relationship in human vasculature and potential 
clinical applicability of these findings via large cohort and lon-
gitudinal studies.
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